Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to journals
Academic Journal

Journal of Medical Ethics

2 Papers Indexed in Blossom

Published Papers

Paywallmeta

Research abuses against people of colour and other vulnerable groups in early psychedelic research

This review of early psychedelic studies (the 50s-70s, s=48) finds that most (77%) would not pass ethical review today. The errors made in early research were extensive dosing, lack of consent, inadequate setting, and lack of scientific hypotheses. The authors make restorative justice and cultural competency suggestions.

Published
July 12, 2021
Journal
Journal of Medical Ethics
Authors
Strauss, D., de la Salle, S., Sloshower, J. A., Williams, M. T.
Open Accessmeta

Ethics and ego dissolution: the case of psilocybin

The paper argues that psilocybin’s characteristic effects—ego dissolution, feelings of unity and ineffability, and attendant lasting personality and worldview changes—create novel ethical risks that standard psychiatric consent procedures may not adequately address. It therefore proposes an enhanced informed consent process with specific discussion prompts, responds to likely objections, and outlines ethical issues for integrating psychedelics into mainstream clinical psychiatry.

Published
May 27, 2020
Journal
Journal of Medical Ethics
Authors
Smith, W. R., Sisti, D.

Quick Facts

Papers Indexed
2
h-Index
93
Open Access
No
Publisher
BMJ
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.